Ad
related to: where is telmisartan manufactured basedgoodrx.com has been visited by 100K+ users in the past month
"Shop around for the best prices without a membership fee." - Today
Search results
Results from the WOW.Com Content Network
Telmisartan, sold under the brand name Micardis among others, is a medication used to treat high blood pressure and heart failure. [ 3 ] [ 6 ] It is a reasonable initial treatment for high blood pressure. [ 6 ]
Twynsta (telmisartan / amlodipine) Viramune ; Consumer Health Care (sold to Sanofi): Antistax (red vine leaf extract) Bisolvon ; Buscopan / Buscapina (hyoscine butylbromide) Dulcolax ; Zantac —75 and 150 mg tablets; 300 mg tablets, syrup and solution for injection are manufactured by GlaxoSmithKline
Telmisartan works by blocking the effects of angiotensin II while amlodipine works by decreasing calcium ion entry into smooth muscle and heart muscle. [2] The combination was approved for medical use in the United States in 2009. [2] The combination is on the World Health Organization's List of Essential Medicines.
In 2010, Sun Pharmaceuticals of India acquired a majority stake in the company. [6] On 22 March 2012, the company's shares were re-listed on the NYSE. In 2013, Sun Pharmaceuticals attempted to buy the remaining shares in the company (it owns 69% stake), but as the company's financial performance improved, shareholders rejected the offer and the company remained publicly listed.
A few clinical head-to-head comparisons have been made and candesartan, irbesartan and telmisartan appear to be slightly more effective than losartan in lowering blood pressure. [4] This difference may be related to different strengths of activity at the receptor level, such as duration and strength of receptor binding. [22]
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland.Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
In 2000, Teva acquired Canada-based Novopharm. [17] In October 2003, Teva announced its intentions to acquire Sicor Inc. for $3.4 billion. [18] Following the announcement, the acquisition was completed on January 22, 2004, which marked Teva's entry into biosimilars' market. [19]
Solid pharmaceutical dosage forms, such as tablets and capsules, and particularly retard formulations, are manufactured at this site. 2007 The acquisition of three European production sites (Germany, Ireland, Italy) from the Japanese pharmaceutical company Astellas on January 1 led to the formation of the Temmler Group, considerably extending ...